Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

carotenoid/vähk

Link salvestatakse lõikelauale
Leht 1 alates 19 tulemused

Formulation and use of carotenoids in treatment of cancer

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION The present invention relates to therapeutic compositions of carotenoids encapsulated in liposomes or other lipid carrier particles. It has been known for more than 50 years that retinoids, the family of molecules comprising both the natural and synthetic analogues of

Formulation and use of carotenoids in treatment of cancer

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION The present invention relates to therapeutic compositions of carotenoids encapsulated in liposomes or other lipid carrier particles. It has been known for more than 50 years that retinoids, the family of molecules comprising both the natural and synthetic analogues of
FIELD OF THE INVENTION This invention relates to carotenoid, retinoid and related conjugated polyene derivatives with cell-differentiation-inducing, anti-proliferative and anti-tumor properties, useful as chemotherapeutic and chemopreventive agents, and more particularly, to such derivatives
The field of this invention is fractionated oxidized carotenoid or retinoid mixtures, and individual components thereof, which are useful as cell-differentiation-inducing, anti-proliferative, anti-metastatic and anti-tumor agents. The mixtures and compounds of the invention can be used alone or in

Carotenoid agent for inhibiting the conversion of epithelial cells to tumors

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION The invention relates to a cartenoid agent for inhibiting the conversion of epithelial cells to tumors and a method for such treatment. More particularly, the invention relates to a cartenoid agent for inhibiting the conversion of melanocytes to melanomas and a method foe such

Aqueous formulations of water-insoluble therapeutic agent comprising carotenoids and/or tocopherols

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION The invention relates to a substantially non-toxic water dispersible therapeutic formulation including a substantially water insoluble therapeutic agent selected from the group consisting of carotenoid compositions and tocopherols that can be administered to animals, including
BACKGROUND OF THE INVENTION 1. The Field of the Invention The present invention relates generally to techniques for measuring levels of chemical compounds found in biological tissue. More specifically, the invention relates to a method and apparatus for the noninvasive detection and measurement of

Structural carotenoid analogs for the inhibition and amelioration of disease

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION 1. Field of the Invention The invention generally relates to the fields of medicinal and synthetic chemistry. More specifically, the invention relates to the synthesis and use of carotenoid analogs. 2. Description of the Relevant Art Cardiovascular disease (CVD), and

Structural carotenoid analogs for the inhibition and amelioration of disease

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION 1 . Field of the Invention The invention generally relates to the fields of medicinal and synthetic chemistry. More specifically, the invention relates to the synthesis and use of carotenoid analogs. 2. Description of the Relevant Art Cardiovascular disease (CVD), and

Lycopene and resveratrol compositions for NK cell activation resulting in anti-neoplastic effect

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CROSS-REFERENCE TO RELATED APPLICATIONS This United States utility patent application is the .sctn.371 national phase of PCT international patent application no PCT/SG2010/000147, having an international filing date of Apr. 13, 2010, which claims benefit of priority to Singapore Patent Applications

Resonance Raman spectroscopy analyzer instrument for biomolecules in tissues and cells

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION 1. Field of the Invention The invention generally relates to methods of detection of cancer and, more specifically, to a Resonance Raman spectroscopy analyzer instrument for biomolecules in tissues and cells. 2. Description of Prior Art Breast cancer is one of the major

Method and compositions for preventing hormone induced adverse effects

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION The present invention provides a method and compositions for preventing adverse effects associated with the administration of hormones such as phytoestrogens and steroidal estrogens. BACKGROUND OF THE INVENTION Hormone intake by humans can occur through, inter alia,

Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION This invention is in the field of biochemistry, pharmacology, and nutritional supplements, and relates to a new use for zeaxanthin, a carotenoid found in plants such as spinach, kale, and corn. Numerous efforts have been made to identify drugs or other biomolecules that

Process for making metabolites of lycopene

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION The present invention is concerned with a multi-stage process for the manufacture of an oxidative metabolite of the carotenoid lycopene as well a novel intermediates produced in the manufacturing process. BACKGROUND OF THE INVENTION As is known, carotenoids, inter alia,

Micronutrient formulations for radiation applications

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION Field of the Invention This invention relates to a use of micronutrient formulations to reduce the effects of radiation on humans. Description of the Related Art Ionizing radiation (X-rays and gamma rays) has proven to be a double-edged sword in clinical Medicine since
Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge